Want to see PTHS full AI Analyst Report?
Pelthos Therapeutics (PTHS) Income Statement
Pelthos Therapeutics Income Statement
Last quarter (Q2 2026), Pelthos Therapeutics's total revenue was $15.60M. In Q2, Pelthos Therapeutics's net income was $-23.42M. See Pelthos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 16.80M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 7.43M | $ 0.00 | $ 0.00 | $ 0.00 | $ -209.05K | |
| $ 39.86M | $ 7.57M | $ 6.86M | $ 2.32M | $ 839.00K | |
| Depreciation and Amortization | $ 2.29M | $ 0.00 | $ 0.00 | $ 0.00 | $ 839.00K |
| $ -45.41M | $ -7.17M | $ -6.86M | $ -2.32M | $ 0.00 | |
| $ -32.43M | $ -7.57M | $ -6.86M | $ -2.32M | $ -839.00K | |
| $ -18.28M | $ -383.89K | $ -518.51K | $ -140.43K | $ 243.61K | |
| $ -50.71M | $ -7.96M | $ -7.38M | $ -2.46M | $ -595.39K | |
| $ -43.32M | $ -7.96M | $ -7.38M | $ -2.46M | $ -595.39K | |
| Per Share Metrics | |||||
| Basic EPS | $ -23.04 | $ -13.54 | $ -12.80 | $ -4.26 | $ -0.10 |
| Diluted EPS | $ -23.04 | $ -13.54 | $ -12.80 | $ -4.26 | $ -0.10 |
| Weighted Average Shares Outstanding | 1.88M | 587.62K | 576.75K | 576.75K | 5.77M |
| Weighted Average Shares Outstanding (Diluted) | 1.88M | 587.62K | 576.75K | 576.75K | 5.77M |
Currency in USD